Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumabl…
Medical - Devices
US, Menlo Park [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 18.85 | 9.28 | 7.81 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -41.07 | -12.31 | -8.73 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | -8.30 | 2.41 | 2.63 | |
| Cash | -11.81 | 2.09 | 2.36 | |
| Capex | -89.90 | -0.01 | < 0.005 | |
| Free Cash Flow | -32.20 | -0.30 | -0.22 | |
| Revenue | -34.10 | 0.14 | 0.22 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -39.48 | 0.11 | 0.19 | |
| Operating Margin | -41.74 | -2.10 | -1.48 | |
| ROA | 0.34 | -0.05 | -0.05 | |
| ROE | -3.00 | -0.12 | -0.12 | |
| ROIC | 1.70 | -0.05 | -0.05 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of PACB is permitted for members.
5
Growth
The "Growth Entry" for the Focus of PACB is permitted for members.
6
Leverage & Liquidity